-
-
-
-
-
-
-
EMA committee recommends approval for Moderna's flu-COVID combo vaccine
-
-
-
-
-
-
-
Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
-
-
-
-
-
-
-
Moderna (MRNA) call put ratio 1.9 calls to 1 put into quarter results
-
-
-
-
-
-
-
Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico
-
-
-
-
-
-
-
Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026
-
-
-
-
-
-
-
Moderna (MRNA) call put ratio 4.4 calls to 1 put with a focus on January calls as share price up 6.8%
-
-
-
-
-
-
-
Jefferies on Moderna (MRNA): '2026 Remains a Covid Story'
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

